Nikkei Average Contribution Ranking (advance closing) ~ The Nikkei Average rebounded slightly for the first time in 4 days, and Fast Rite boosted by about 41 yen per brand
The number of gains and falls of the Nikkei Average constituent stocks at the time of closing 31 days ago was 2 stocks unchanged: 177 stocks with price increases and 46 stocks with price drops. The Nikkei Average rebounded for the first time in 4 business days. The front-end transaction was closed at 38119.96 yen (estimated volume of 750 million shares), which was 65.83 yen higher (+0.17%) compared to the previous day. The US stock market continued to decline on the 30th. The Dow average depreciated by $330.06 (-0.86%) at $38111.48, and the Nasdaq depreciated 183.50 points (-1.08%) by 1
Qpex Biopharma, a Shionogi Group Company, Receives an Additional $10M Award by BARDA as Part of Qpex's Partnership to Advance Its Portfolio of Antibiotics Addressing Drug-Resistant Infections
Qpex Biopharma, Inc., a Shionogi Group Company, (hereafter "Qpex") today announced the exercise of a $10 million option from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration
Nikkei Average Contribution Ranking (advance closing) ~ The Nikkei Average fell, and TOEREC was pushed down by about 45 yen per brand
The number of gains and falls of the Nikkei Average constituent stocks at the time of closing 28 days ago was 112 stocks with price increases and 111 stocks with price drops unchanged. The Nikkei Average fell slightly. The forward market transaction was closed at 38783.27 yen (estimated volume of 750 million shares), which was 116.75 yen lower (-0.30%) than the previous day. The UK market and US market on the 27th are closed due to a public holiday. In the exchange market, exchange transactions for major currencies continued to be in a state of lack of momentum, but the dollar remained somewhat steady. The dollar and yen are 156 yen 7
Nikkei average contribution ranking (advance closing) ~ The Nikkei Average fell drastically, and TOEREC was pushed down by about 91 yen per brand
The number of gains and falls of the Nikkei Average constituent stocks as of closing 24 days ago was 65 stocks with price increases, 156 stocks with price drops, and 4 stocks unchanged. The Nikkei Average fell sharply. The forward market transaction was closed at 38649.15 yen (estimated volume of 730 million shares), which was 454.07 yen lower (-1.16%) compared to the previous day. The US stock market continued to decline on the 23rd. The Dow average depreciated by $605.78 (-1.53%) to $39065.26, and the Nasdaq depreciated 65.50 points (-0.39%) to 16736.
Nikkei Average Contribution Ranking (advance closing) ~ The Nikkei Average continues to decline, with Fast Rite being pushed down by about 71 yen per brand
The number of gains and falls of the Nikkei Average constituent stocks as of closing 22 days ago was 65 stocks with price increases, 156 stocks with price drops, and 4 stocks unchanged. The Nikkei Average continues to fall. The forward market transaction was closed at 38719.35 yen (estimated volume of 760 million shares), which was 227.58 yen lower (-0.58%) compared to the previous day. The US stock market rose on the 21st. The Dow average was $66.22 higher (+ 0.17%) at $39872.99, and the NASDAQ was 37.75 points higher (+ 0.22%) at 16832.63,
Nikkei average contribution ranking (advance closing) ~ The Nikkei average continues to rise, and Advantest boosts 1 brand by about 31 yen
The number of gains and falls of the Nikkei Average constituent stocks as of closing 21 days ago was 123 stocks with price increases, 101 stocks with price drops, and 1 stock unchanged. The Nikkei Average continues to rise. The front-end transaction was closed at 39135.91 yen (estimated turnover 800 million shares), which was 66.23 yen higher (+0.17%) compared to the previous day. The US stock market on the 20th was mixed. The Dow average depreciated by 196.82 dollars (-0.49%) to 39806.77 dollars, and the NASDAQ rose 108.91 points (+ 0.65%) to 16794.88, S
Iida GHD, Fujifilm, etc. (added) Rating
Upgraded - Bullish Code | Stock Name | Securities Company | Conventional | After Change |------|--------------|------------|----------|----------|<1801>|Taiseiken | Nomura | “Neutral” | “Buy” | Downgrade-Bearish Code | Stock Name | Securities Company | Traditional | After Change |------|------------
Nikkei Average Contribution Ranking (advance closing) ~ The Nikkei Average fell for the first time in 4 days, and East Elec was pushed down by about 72 yen per brand
The number of gains and falls of the Nikkei average constituent stocks as of closing 17 days ago was 109 stocks with price increases, 115 stocks with price drops, and 1 stock unchanged. The Nikkei Average fell for the first time in 4 days. The forward market transaction was closed at 38782.08 yen (estimated turnover of 920 million shares), which was 138.18 yen lower (-0.36%) compared to the previous day. The US stock market fell on the 16th. The Dow average depreciated by 38.62 dollars (-0.10%) to 39869.38 dollars, and the Nasdaq depreciated by 44.07 points (-0.26%) to 1669
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <1780> Yamaura 1369 1412 <1786> Oriental Shiraishi 355 387 <1805> Tobishima Ken 1370 1429 <1812> Kashima 2715 3057 <1833> Okumura Gumi 4840 501
List of Unrivaled Stocks (Part 2) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○List of Unbroken Stocks Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1786> Oriental Shiraishi 355 397.5 380 <1803> Shimizu Ken 912 947.5 953 <1812> Kashima 2715 3028.25 2888.5 <1950> Japan
FunPep - 1Q concludes an option agreement with Shionogi Pharmaceutical regarding the antibody-inducing peptide “FPP004X”
FunPep <4881> announced consolidated financial results for the 1st quarter (January to March 24) of the fiscal year ending 2024/12 on the 13th. Sales increased 54.8% from the same period last year to 50 billion yen, operating loss was 183 million yen (loss of 378 million yen in the same period last year), ordinary loss was 170 million yen (loss of 343 million yen), and quarterly net loss attributable to parent company shareholders was 168 million yen (341 million yen). About the antibody-inducing peptide project, the antibody-inducing peptide “FPP003” (label
The mood intensifies before the US inflation index is announced
The Nikkei Average rebounded. The transaction closed at 38356.06 yen (estimated turnover of 2.11 billion shares), which rose by 176.60 yen. Overseas media reported that US Intel “will receive funding from a US investment company” in the construction plan for a semiconductor factory in Ireland, and since it was bought in the US market the day before, one part of semiconductor-related stocks etc. became strong in the Tokyo market, and the Nikkei Average rose to 38477.68 yen right after falling close. However, domestic long-term interest rates rose due to speculations about policy normalization by the Bank of Japan
Nikkei Average Contribution Ranking (advance closing) ~ The Nikkei Average rebounded slightly, and Advantest boosted by about 33 yen with 1 brand
The number of gains and falls of the Nikkei Average constituent stocks as of closing 14 days ago was 102 stocks with price increases, 123 stocks with price drops, and 0 stocks unchanged. The Nikkei Average rebounded slightly. The front-end transaction was closed at 38199.10 yen (estimated turnover of 990 million shares), 19.64 yen higher (+0.05%) compared to the previous day. The US stock market on the 13th was mixed. The Dow average depreciated by $81.33 (-0.21%) to $39431.51, and the Nasdaq rose 47.37 points (+ 0.29%) to 16388
Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 5/13)
[Good material] ---- ---- ■Miraite One [Tokyo Stock Exchange P] This fiscal year's earnings will increase by 50% and dividends by 10 yen. Also, stock buybacks will be carried out up to 1.5 million shares (2 billion yen in value), which is 1.63% of the number of issued shares (excluding company shares). The purchase period is from 5/14 to 9/30. ■ROBOT HOME [Tokyo Stock Exchange S] January-March (1Q) regular accounts landed with a 2.6 times increase in profit. ■ETS Holdings
Shionogi: 2023 financial results briefing materials
Shionogi 4Q R&D Expenses Y30.0B Vs. Y27.6B Year Earlier
Shionogi 4Q R&D Expenses Y30.0B Vs. Y27.6B Year Earlier
Shionogi Expects FY HIV Franchise Royalty Income at Y224.6B Vs. Y195.8B
Shionogi Expects FY HIV Franchise Royalty Income at Y224.6B Vs. Y195.8B
Shionogi Expects FY Japan Prescription Drugs Revenue to Fall 11% to Y134.9B
Shionogi Expects FY Japan Prescription Drugs Revenue to Fall 11% to Y134.9B
Shionogi 4Q Net Profit Missed Y37.6B Expected in Poll of Analysts by Visible Alpha
Shionogi 4Q Net Profit Missed Y37.6B Expected in Poll of Analysts by Visible Alpha
Shionogi 4Q Rev Y98.3B Vs. Y88.3B >4507.TO
Shionogi 4Q Rev Y98.3B Vs. Y88.3B >4507.TO
No Data